MiNK Therapeutics INKT
NASDAQ INKT
$10.06 -0.56 (-5.27%)
At close: Oct 22, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Interest Expenses (2020 - 2022)

Updated

MiNK Therapeutics (INKT) reported Interest Expenses of $848.00 for Q1 2022, down 99.9% from $743,695 a year earlier and down 99.9% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Interest Expenses (2020 - 2022) Analysis & Trends

Over the twelve months ended Mar 31, 2022, MiNK Therapeutics' Interest Expenses came in at $2.43 million; for FY2021, it was $2.43 million, down 0.4% from FY2020.

  • By year, Interest Expenses came in at $2.44 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 247.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 MiNK Therapeutics 51.27 Mn 10.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 848.00
Dec 31, 2021 805,049.00
Sep 30, 2021 881,323.00
Mar 31, 2021 743,695.00
Dec 31, 2020 686,785.00
Sep 30, 2020 639,026.00
API Access

MiNK Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=INKT&period=max&api_key=YOUR_API_KEY